These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 1646250)

  • 21. Treatment of Paget's disease of bone with salmon calcitonin nasal spray.
    Gagel RF; Logan C; Mallette LE
    J Am Geriatr Soc; 1988 Nov; 36(11):1010-4. PubMed ID: 3171038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Formation of neutralizing antibodies during intranasal synthetic salmon calcitonin treatment of postmenopausal osteoporosis.
    Muff R; Dambacher MA; Fischer JA
    Osteoporos Int; 1991 Feb; 1(2):72-5. PubMed ID: 1790395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of osteoporosis and Paget's disease.
    Stewart GO; Nicholson GC
    Curr Opin Rheumatol; 1991 Jun; 3(3):380-7. PubMed ID: 1883692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [On the treatment of the osteodystrophia deformans (Paget's disease) with synthetic salmon calcitonin (author's transl)].
    Trzenschik K; Schmidt UJ; Abendroth K; Ansorg H; Graner H; Lindenhayn K; Schramm G; Kalbe I
    Z Alternsforsch; 1978; 33(5):441-51. PubMed ID: 570764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of alendronate and intranasal calcitonin for treatment of osteoporosis in postmenopausal women.
    Downs RW; Bell NH; Ettinger MP; Walsh BW; Favus MJ; Mako B; Wang L; Smith ME; Gormley GJ; Melton ME
    J Clin Endocrinol Metab; 2000 May; 85(5):1783-8. PubMed ID: 10843152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of prolonged thyrocalcitonin administration on Paget's disease of bone.
    Haddad JG; Birge SJ; Avioli LV
    N Engl J Med; 1970 Sep; 283(11):549-55. PubMed ID: 5450609
    [No Abstract]   [Full Text] [Related]  

  • 27. [Bisphosphonates and bone remodeling: effectiveness in Paget's disease, fibrous dysplasia and osteoporosis].
    Chapurlat R; Meunier PJ
    Rev Chir Orthop Reparatrice Appar Mot; 1998 Nov; 84(8):743-51. PubMed ID: 10192126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nasal calcitonin for treatment of established osteoporosis.
    Overgaard K; Riis BJ; Christiansen C; Pødenphant J; Johansen JS
    Clin Endocrinol (Oxf); 1989 Apr; 30(4):435-42. PubMed ID: 2688995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neutralizing antibodies against calcitonin.
    Grauer A; Reinel HH; Ziegler R; Raue F
    Horm Metab Res; 1993 Sep; 25(9):486-8. PubMed ID: 8225203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Response of Paget's disease to human calcitonin in patients resistant to porcine calcitonin.
    Lo Cascio V; Adami S; Galvanini G; Lazzaretto R; Ferrari M; Tartarotti D; Scuro LA
    J Endocrinol Invest; 1984 Apr; 7(2):85-8. PubMed ID: 6725870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Short-term biological effects of synthetic salmon calcitonin in Paget's disease. Influence of posology].
    Chapuy MC; Meunier P; Terrier M; David L; Vignon G
    Pathol Biol (Paris); 1975 May; 23(5):349-59. PubMed ID: 172838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effectiveness of intranasal salmon calcitonin treatment in postmenopausal osteoporosis].
    Kopaliani M
    Georgian Med News; 2005 Apr; (121):38-42. PubMed ID: 15908722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Salmon calcitonin: a review of current and future therapeutic indications.
    Chesnut CH; Azria M; Silverman S; Engelhardt M; Olson M; Mindeholm L
    Osteoporos Int; 2008 Apr; 19(4):479-91. PubMed ID: 18071651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paget's disease of bone (osteitis deformans) treated with human synthetic calcitonin.
    Epstein S; Owen G
    S Afr Med J; 1977 Jan; 51(5):133-7. PubMed ID: 850845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination drug therapy in treatment of Paget's disease of bone: clinical and metabolic response.
    Hadjipavlou AG; Tsoukas GM; Siller TN; Danais S; Greenwood F
    J Bone Joint Surg Am; 1977 Dec; 59(8):1045-51. PubMed ID: 145441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Combined treatment of Paget's disease of bone with calcitonin and the diphosphonate EHDP].
    Jaeger P; Bischoff-Delaloye A; Burckhardt P
    Schweiz Med Wochenschr; 1981 Dec; 111(49):1893-7. PubMed ID: 6800028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis.
    Hodsman AB; Fraher LJ; Watson PH; Ostbye T; Stitt LW; Adachi JD; Taves DH; Drost D
    J Clin Endocrinol Metab; 1997 Feb; 82(2):620-8. PubMed ID: 9024265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcitonins: newer routes of delivery.
    Reginster JY
    Osteoporos Int; 1993; 3 Suppl 2():S3-6; discussion S6-7. PubMed ID: 8481597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparison of calcitonin tolerance after intramuscular or intranasal administration in treatment for postmenopausal osteoporosis].
    Horst-Sikorska W; Ruszkowska J; Kosowicz J
    Przegl Lek; 1996; 53(1):9-11. PubMed ID: 8711177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Influence of porcine calcitonin in 3 healthy patients and in a female patient with Paget's disease].
    Aznar Reig A; Zamora Madaria E; Herrera Justiniano E; Rubio Rubio JM; Gómez San Millán M; Merchante C
    Rev Iber Endocrinol; 1971; 18(107):419-42. PubMed ID: 5133441
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.